bpc-157 fda category 2 compounding Adds Several Peptides to Bulks List, Restricting Them From — Restore Health Consulting You may have heard buzz
You may have heard buzz about 14 peptides potentially returning to legal compounding. Here's what we know: HHS Secretary RFK Jr. stated his intention to move these peptides from FDA Category 2 fda bpc 157 status fda bpc 157 category 2 bulk drug substances compounding list When will the FDA reclassify BPC 157 to Category 1 Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA panel votes to place popular peptide BPC 157 on compounding list Reuters BREAKING: The FDA just reversed theIR 2023 peptide ban. 12 peptides were just pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu (injectable)
Pay in 4 interest-free payments of $6.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


